I. Tadros
Pavitra lives in Shiv Sadan village; he was affected with leprosy. He's now cured. Based on his capabilities, he's currently leading a life of dignity and contributing to the well being of the community.
© Credits

Leprosy (Hansen's disease)

    Overview

    Leprosy, also known as Hansen’s disease, is a chronic infectious disease caused by Mycobacterium leprae. The disease mainly affects the skin, the peripheral nerves, mucosal surfaces of the upper respiratory tract and the eyes. Leprosy is known to occur at all ages ranging from early infancy to very old age. Leprosy is curable and treatment in the early stages can prevent disability.

    Leprosy is likely transmitted via droplets, from the nose and mouth, during close and frequent contact with untreated cases.

    Symptoms

    Symptoms may occur within 1 year but can also take as long as 20 years or even more to occur.

    Clinical signs are easy to observe. Skin lesion has usually a different pigmentation than the surrounding normal skin (less pigmented, reddish or copper-coloured) and may have various aspects (flat, raised or nodules). Skin lesion can be single or multiple and may show a loss of sensation in the skin.

    Skin smears are also used to diagnose leprosy.

    Leprosy can be classified on the basis of clinical manifestations and skin smear results. In the classification based on skin smears, patients showing negative smears at all sites are said to have paucibacillary leprosy (PB), while those showing positive smears at any site are said to have multibacillary leprosy (MB).

    Treatment

    Leprosy is curable with a combination of drugs known as multidrug therapy, as the treatment of leprosy with only one antileprosy drug (monotherapy) will result in development of drug resistance to that drug. The combination of drugs used in the MDT depends on the classification of the disease (paucibacillary or multibacillary leprosy).

    News

    All →

    Our work

    Publications

    All →
    Global consultation of National Leprosy Programme managers, partners and affected persons on Global Leprosy Strategy 2021–2030
    Report of the virtual meeting 26–30 October 2020
    Leprosy/Hansen disease: Contact tracing and post-exposure prophylaxis

    “In order to bring down the case detection among leprosy contacts from Point A to Point B, programmes can choose to treat 100 contacts with leprosy...

    Global leprosy (Hansen disease) update, 2019: time to step-up prevention initiatives

    Leprosy is a neglected tropical disease (NTD), which still occurs in more than 120 countries, with more than 200 000 new cases reported...

    World Leprosy Day

    World Leprosy Day

    Every last Sunday of January

    Mission Leprosy
    © Credits

    Related links

    Peer-reviewed publications (PubMed)

    International Leprosy Association

    Research

     

    Contact

    Dr. Erwin Cooreman
    Team Leader

    Telephone: +91 11 233 09 489 | GPN 26489
    Mobile phone: +91 965 01 97 389
    [email protected]


    Ashok Moloo
    Information officer

    Telephone: +41 22 791 16 37
    Mobile phone: +41 79 540 50 86
    @ntdworld